138 related articles for article (PubMed ID: 1491358)
1. From an animal model of an attentional deficit towards new insights into the pathophysiology of schizophrenia.
Feldon J; Weiner I
J Psychiatr Res; 1992 Oct; 26(4):345-66. PubMed ID: 1491358
[TBL] [Abstract][Full Text] [Related]
2. Amphetamine-produced attenuation of latent inhibition is modulated by stimulus preexposure duration: implications for schizophrenia.
De la Casa LG; Ruiz G; Lubow RE
Biol Psychiatry; 1993 May; 33(10):707-11. PubMed ID: 8353165
[TBL] [Abstract][Full Text] [Related]
3. Latent inhibition and schizophrenia: Pavlovian conditioning of autonomic responses.
Vaitl D; Lipp O; Bauer U; Schüler G; Stark R; Zimmermann M; Kirsch P
Schizophr Res; 2002 May; 55(1-2):147-58. PubMed ID: 11955974
[TBL] [Abstract][Full Text] [Related]
4. The latent inhibition model of schizophrenic attention disorder. Haloperidol and sulpiride enhance rats' ability to ignore irrelevant stimuli.
Feldon J; Weiner I
Biol Psychiatry; 1991 Apr; 29(7):635-46. PubMed ID: 2054435
[TBL] [Abstract][Full Text] [Related]
5. The role of mesolimbic dopaminergic and retrohippocampal afferents to the nucleus accumbens in latent inhibition: implications for schizophrenia.
Gray JA; Joseph MH; Hemsley DR; Young AM; Warburton EC; Boulenguez P; Grigoryan GA; Peters SL; Rawlins JN; Taib CT
Behav Brain Res; 1995 Nov; 71(1-2):19-31. PubMed ID: 8747172
[TBL] [Abstract][Full Text] [Related]
6. Integrating schizophrenia.
Gray JA
Schizophr Bull; 1998; 24(2):249-66. PubMed ID: 9613624
[TBL] [Abstract][Full Text] [Related]
7. Loss of the Kamin blocking effect in acute but not chronic schizophrenics.
Jones SH; Gray JA; Hemsley DR
Biol Psychiatry; 1992 Nov; 32(9):739-55. PubMed ID: 1360261
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of latent inhibition in patients with chronic schizophrenia.
Gal G; Barnea Y; Biran L; Mendlovic S; Gedi T; Halavy M; Feldon J; Fennig S; Levkovitz Y
Behav Brain Res; 2009 Jan; 197(1):1-8. PubMed ID: 18793680
[TBL] [Abstract][Full Text] [Related]
9. The latent inhibition model of schizophrenia: further validation using the atypical neuroleptic, clozapine.
Weiner I; Shadach E; Tarrasch R; Kidron R; Feldon J
Biol Psychiatry; 1996 Nov; 40(9):834-43. PubMed ID: 8896769
[TBL] [Abstract][Full Text] [Related]
10. Latent inhibition in schizophrenia.
Swerdlow NR; Braff DL; Hartston H; Perry W; Geyer MA
Schizophr Res; 1996 May; 20(1-2):91-103. PubMed ID: 8794497
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of microinjections of d-amphetamine into the nucleus accumbens or the caudate putamen on the rat's ability to ignore an irrelevant stimulus.
Solomon PR; Staton DM
Biol Psychiatry; 1982 Jun; 17(6):743-56. PubMed ID: 7104422
[TBL] [Abstract][Full Text] [Related]
12. Learned irrelevance is disrupted in first-episode but not chronic schizophrenia patients.
Gal G; Mendlovic S; Bloch Y; Beitler G; Levkovitz Y; Young AM; Feldon J; Ratzoni G
Behav Brain Res; 2005 Apr; 159(2):267-75. PubMed ID: 15817189
[TBL] [Abstract][Full Text] [Related]
13. Gender- and age-dependent differences in latent inhibition following pre-weaning non-handling: implications for a neurodevelopmental animal model of schizophrenia.
Shalev U; Feldon J; Weiner I
Int J Dev Neurosci; 1998; 16(3-4):279-88. PubMed ID: 9785124
[TBL] [Abstract][Full Text] [Related]
14. The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment.
Weiner I
Psychopharmacology (Berl); 2003 Sep; 169(3-4):257-97. PubMed ID: 12601500
[TBL] [Abstract][Full Text] [Related]
15. Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia.
Zuckerman L; Rehavi M; Nachman R; Weiner I
Neuropsychopharmacology; 2003 Oct; 28(10):1778-89. PubMed ID: 12865897
[TBL] [Abstract][Full Text] [Related]
16. Disrupted latent inhibition in the rat with chronic amphetamine or haloperidol-induced supersensitivity: relationship to schizophrenic attention disorder.
Solomon PR; Crider A; Winkelman JW; Turi A; Kamer RM; Kaplan LJ
Biol Psychiatry; 1981 Jun; 16(6):519-37. PubMed ID: 7196265
[TBL] [Abstract][Full Text] [Related]
17. Scopolamine induces disruption of latent inhibition which is prevented by antipsychotic drugs and an acetylcholinesterase inhibitor.
Barak S; Weiner I
Neuropsychopharmacology; 2007 May; 32(5):989-99. PubMed ID: 16971898
[TBL] [Abstract][Full Text] [Related]
18. Towards an animal model of an antipsychotic drug-resistant cognitive impairment in schizophrenia: scopolamine induces abnormally persistent latent inhibition, which can be reversed by cognitive enhancers but not by antipsychotic drugs.
Barak S; Weiner I
Int J Neuropsychopharmacol; 2009 Mar; 12(2):227-41. PubMed ID: 18687163
[TBL] [Abstract][Full Text] [Related]
19. MAM (E17) rodent developmental model of neuropsychiatric disease: disruptions in learning and dysregulation of nucleus accumbens dopamine release, but spared executive function.
Howe WM; Tierney PL; Young DA; Oomen C; Kozak R
Psychopharmacology (Berl); 2015 Nov; 232(21-22):4113-27. PubMed ID: 25963563
[TBL] [Abstract][Full Text] [Related]
20. Conditional stimulus probability and activity of hippocampal, cingulate cortical, and limbic thalamic neurons during avoidance conditioning in rabbits.
Stolar N; Sparenborg S; Donchin E; Gabriel M
Behav Neurosci; 1989 Oct; 103(5):919-34. PubMed ID: 2803559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
